Home » Featured » Page 25
Featured
Although a United States Food and Drug Administration (FDA)-approved prescription medication, the Centers for Disease Control and Prevention (CDC) issued a warning last week that the drug ivermectin is not meant to be used for prevention or treatment of COVID-19.
Failing to heed that warning... Read More »
A new policy brief released this month by the advocacy group Pandemic Action Network (PAN) calls on world leaders to create a 100-day action plan toward creating a new financing mechanism at the United Nations General Assembly capable of bolstering pandemic preparedness by at least $10 billion... Read More »
New voices were added to the United States Department of Health and Human Services’ (HHS) Tick-Borne Disease Working Group this week, filling positions left vacant by public members looking to workshop ideas on how best to counter rising cases of tick-borne illnesses.
In all, seven new members... Read More »
New data released by Johnson & Johnson this week showed that using its single-shot COVID-19 vaccine as a booster for the previously vaccinated could provide as much as a nine-fold increase in antibodies for patients at least 18 years old.
The news follows interim reports from July, published in... Read More »
With data from its Phase 3 COVE study showing a COVID-19 vaccine with 93 percent effectiveness, Moderna, Inc. has officially filed for a biologics license application (BLA) to the United States Food and Drug Administration (FDA) that would lead to full licensure.
It’s an important step, which... Read More »
A 210-person Phase 2 clinical trial for the COVID-19 vaccine candidate, ABNCoV2, began this week to determine its potential as a booster vaccine for those who have either caught the disease previously or been otherwise vaccinated.
Licensed by Bavarian Nordic A/S and developed by AdaptVac, the... Read More »
Results of a Phase 3 clinical trial have shown that AstraZeneca’s antibody combination for COVID-19, AZD7442, cuts the risk of symptomatic COVID-19 cases by 77 percent for at least three months.
That is dependent on the treatment being taken prior to infection. However, the antibodies used in... Read More »
The United States Food and Drug Administration (FDA) on Monday granted full approval to Pfizer-BioNTech’s COVID-19 vaccine for use among patients 16 years and older, making it the first of the disease’s vaccines to cross beyond conditional use.
Since Dec. 11, 2020, the mRNA-based vaccine had... Read More »
While key federal agencies prepared interagency response plans and conducted 74 interagency exercises from 2009 through 2019 to prepare for and respond to a wide variety of biological incidents, the Government Accountability Office (GAO) recently determined that the agencies weren’t on the same... Read More »
Utilizing initial funding from the American Rescue Plan, the U.S. Centers for Disease Control and Prevention (CDC) unveiled plans this week for a new Center for Forecasting and Outbreak Analytics, focused on forecasts of disease outbreaks and analytics for public health.
The new center will be... Read More »
As part of a new agreement with Gritstone bio, Inc., the Coalition for Epidemic Preparedness Innovations (CEPI) will provide up to $20.6 million to support the development of a new, self-amplifying mRNA vaccine candidate for the growing number of COVID-19 variants.
These funds will cover a... Read More »
The World Health Organization (WHO) is asking for $7.7 billion in funding for the Rapid ACT-Accelerator Delta Response (RADAR) to help stop the Delta variant and bring about an end to the COVID-19 pandemic.
The funding would allow for increased testing and better surveillance to detect and... Read More »
The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) last week authorized the use of third COVID-19 vaccine doses from Pfizer Inc. and Moderna Inc. for patients with compromised immune systems.
The decision follows months of build-up surrounding... Read More »
The more than 25,000 healthcare workers employed by the U.S. Department of Health and Human Services (HHS) will need to be vaccinated against COVID-19, adding it to a list of requirements that include influenza and other routine vaccinations.
“Our number one goal is the health and safety of... Read More »
In a letter to federal officials, eight senators from the Western United States called for coordination and development of a strategy to counter jet fuel shortages, which they fear could exacerbate the dangers of wildfire season through grounded aircraft.
“As you are well aware, the 2020... Read More »
Members of Congress this summer ramped up bipartisan efforts with the introduction of at least eight bills that seek to help the United States prepare for and respond to pandemics and other public health emergencies.
Most recently, the Disease X Act, S. 2640, proposed on Aug. 5 by U.S. Sens.... Read More »
A budget push from U.S. Sens. Richard Shelby (R-AL), Jim Inhofe (R-OK), and Roger Wicker (R-MS) seeks to require the Senate Armed Services Committee (SASC) to report reconciliation legislation of $50.2 billion for military infrastructure improvements, among other items.
If accepted, their... Read More »
Regulatory approval was granted for two new clinical trials of INO-4800 in China this week, allowing its creator INOVIO and its partners Advaccine Biopharmaceuticals Suzhou Co. Ltd. and Sinovac Biotechnology to investigate the safety, tolerability, and immunogenicity of different... Read More »
President Joe Biden approved more than $3.46 billion Thursday for Hazard Mitigation Grants to increase state’s resilience to the impacts of climate change.
The investment will be available for natural hazard mitigation measures across the 59 major disaster declarations issued due to the... Read More »
U.S. Sen. Tammy Baldwin (D-WI) introduced legislation last week that would allocate $2 billion to the Biomedical Advanced Research and Development Authority (BARDA).
The Disease X Act would provide $2 billion over the next four years -- $500 million per year, beginning in 2022 -- for BARDA to... Read More »
A cocktail of casirivimab and imdevimab known as REGEN-COV, produced by Regeneron Pharmaceuticals, Inc., cut the risk of symptomatic infections by 81 percent in a Phase 3 trial of more than 1,500 people, according to a new publication in the New England Journal of Medicine.
Even better,... Read More »
A new report released this week by United States Sens. Rob Portman (R-OH) and Gary Peters (D-MI) revealed glaring cybersecurity failures at eight federal agencies over the past decade, along with the inability of seven of them to comply with basic cybersecurity requirements.
The Federal... Read More »
In a letter dispatched last week, five U.S. representatives called on Health and Human Services Secretary Xavier Becerra to tap domestic manufacturing and new technologies to grow the national stockpile of important pharmaceuticals and reduce reliance on foreign production.
Although the... Read More »
REGEN-COV was confirmed for continued use against COVID-19 cases deemed at high risk for progression to hospitalization or death last week, with the extension of its Emergency Use Authorization by the United States Food and Drug Administration (FDA).
The therapeutic is a monoclonal antibody... Read More »
Following a new National Security Memorandum signed by President Joe Biden aimed at strengthening cybersecurity for the nation’s critical infrastructure, a bipartisan group of U.S. senators recently introduced the Defense of United States Infrastructure Act, S. 2491, legislation aimed at... Read More »
State funding for public health departments has dropped by 16 percent since 2010, and these same departments have lost a quarter of their workforce in the last decade.
How can the United States adequately prepare for the next pandemic when the public health infrastructure is woefully... Read More »
In a first for virus detection, the company Opteev this week launched a plug-in airborne virus detector known as ViraWarn to scan for COVID-19, flu, and other virus particles in the air indoors and then warn those who might be affected.
Meant as prevention rather than confirmation of infection,... Read More »
Recognizing that many data sets are needed to tell the full story of the COVID-19 pandemic and understand if herd immunity can be achieved, two scientists from the University of Washington have created a statistical model of key COVID-19 data to model the disease’s true prevalence in the United... Read More »
In a letter written to Senate Majority Leader Chuck Schumer (D-NY) and Speaker of the House Nancy Pelosi (D-CA), more than 70 U.S. representatives and senators have called for providing up to $34 billion to speed up COVID-19 vaccine production for global use.
“No investment in the fight... Read More »
Drawing on funds from the American Rescue Plan, the Biden administration announced last week that its Department of Health and Human Services (HHS) will invest more than $1.6 billion into testing and mitigation efforts focused on the communities most vulnerable to COVID-19.
“As we continue... Read More »
U.S. Sens. Mark Warner (D-VA), Marco Rubio (R-FL), and Susan Collins (R-ME) introduced Wednesday the Cyber Incident Notification Act of 2021, which seeks to make it mandatory for federal agencies, government contractors, and critical infrastructure to report cyber intrusions to the Cybersecurity... Read More »
Pushing back against the string of cybersecurity threats instigated this year, the United States Transportation Security Administration (TSA) issued a new Security Directive this week that requires owners and operators of critical pipelines to roll out urgent cyber protections.
“Secure... Read More »
On Monday, the Infectious Diseases Society of America commended the U.S. House for appropriations that would bolster the fight against COVID-19 and HIV, antibiotic research and development, and global health security while combating the effects of the opioid crisis.
However, the organization... Read More »
Given the destructive nature of the past year and a half under the COVID-19 pandemic, U.S. Rep. Eric Swalwell (D-CA) last week introduced two bills to strengthen pandemic response and treat them as national security threats rather than political minefields.
First was the National Security... Read More »
Partners in COVAX, a global collaborative effort to accelerate development, manufacturing and equitable access to COVID-19 vaccines, launched the COVAX Marketplace last week to match buyers with suppliers through a secure new platform and overcome short-term bottlenecks.
The Marketplace is a... Read More »
